Progress continues, however, with both women-exclusive randomized control trials 3 and observational prospective studies currently being conducted. 4 The information generated from this research has increased our understanding of the determinants of and medical therapies to prevent stroke in women, yet some questions remain, and ongoing surveillance of stroke incidence and outcomes after stroke is required.In high-income countries, like the United States, women have a greater lifetime risk of stroke than men. Further, stroke rates differ by ethnoracial origin with a higher stroke rate occurring in Black and Hispanic women living in the United States. The major risk factors for stroke and the strength of association of the risk factors are similar in women and men, with preeclampsia, pregnancy, and use of exogenous hormones as the few exceptions. However, the frequency of each risk factor, and therefore the population attributable risk, differs between the sexes. As shown in the international INTERSTROKE case-control study, 5 hypertension, abdominal obesity, and adverse lipid profile are the most impactful causes of stroke in women worldwide, with smoking, cardiac causes, and lifestyle factors (ie, diet quality, exercise, alcohol use) remaining as important, but not as frequent, risk factors. It is through screening and treatment of these common risk factors where the greatest gains in stroke prevention can occur. After a stroke occurs, ensuring equal access to health care and evidence-based stroke management will equalize stroke outcomes by sex. Although progress has been made, with the first guideline specifically targeted to stroke in women recently published, 6 implementation of the optimal screening and treatment for women at risk for stroke is urgently needed.In today's edition of Stroke, a series of 4 articles present aspects of stroke physiology and epidemiology unique to women: the vascular biology of preeclampsia and its relationship to stroke; hormonal risk factors for stroke in women; an update on classical stroke risk factors in women; and sex/gender differences in stroke outcomes. Underscoring all of these sex-and gender-specific differences is a call for more intensive risk factor modification throughout the entirety of a woman's life course.Pregnancy is often the first major stroke risk factor experienced by young women. As McDermott et al 7 attest, stroke affects ≈30 women for every 100 000 pregnancies. Although hormonal factors, peripartum illness, and hemodynamic factors play a role, the majority of events are mediated through the spectrum of hypertensive disorders in pregnancy, particularly preeclampsia/toxemia. A systemic, multiorgan endotheliopathy, preeclampsia both predisposes to the malignant edema in posterior reversible encephalopathy syndromes and confers a 40-fold risk increase for true ischemic stroke. The most important prevention strategy is early detection, which should be emphasized with frequent antenatal blood pressure measurements and screening for signs and symptoms of toxemi...